A second chance for microbicides.
Baleta
Adele
A
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D063065:Organophosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D015995:Prevalence; D019035:Rural Health Services / Q000458:organization & administration* / Q000639:trends; D011477:Sex Work / Q000706:statistics & numerical data; D013019:South Africa / Q000453:epidemiology; D000068698:Tenofovir; D014622:Vaginal Creams, Foams, and Jellies
D019380:Anti-HIV Agents; D000890:Anti-Infective Agents; D063065:Organophosphonates; D014622:Vaginal Creams, Foams, and Jellies; D000068698:Tenofovir; D000225:Adenine